Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTSI.L Regulatory News (TSI)

  • There is currently no data for TSI

BrandShield Contract Win

17 Nov 2020 07:00

RNS Number : 5510F
Two Shields Investments PLC
17 November 2020
 

17 November 2020

 

Two Shields Investments plc

("TSI", or the "Company")

 

BrandShield Contract Win

 

Two Shields Investments plc is pleased to reproduce the following announcement on behalf of BrandShield Limited ("BrandShield"). As announced on 11 November 2020, TSI has conditionally agreed to acquire the shares of BrandShield, not currently held by TSI, and proposes to change the name of the Company to BrandShield Systems Plc. TSI currently has an 11.34% shareholding and a Convertible Loan Note subscription of $1.8m (which when converted gives TSI a total shareholding of circa 20% of BrandShield).

"BrandShield wins major contract with Pharmaceutical Security Institute

BrandShield will help several Pharmaceutical Security Institute members remove online threats such as rogue pharmacies and counterfeit websites, including those related to COVID-19 vaccines.

 

BrandShield, a leading provider of cyber solutions from brand protection to online threat hunting, today announces that it has been awarded a contract with the Pharmaceutical Security Institute ("PSI").

Based in Washington, D.C, PSI was set up in 2002 by the Security Directors from fourteen major pharmaceutical companies. Working with its members, PSI has developed improved systems to identify the extent of the problem of counterfeit medicinal products and to assist in coordinating international inquiries.

BrandShield has entered into a contract with PSI on a joint programme to focus on helping to detect and remove online threats on behalf of several of PSI's members, such as rogue pharmacies, counterfeit sales of drugs on online marketplaces, and social media phishing campaigns, and other fraudulent online activities. These members include some involved in developing COVID-19 vaccines.

The contract is another major step in the development of BrandShield. BrandShield recently announced it had raised £3.2 million in new funding and is expected to list via a reverse takeover of Two Shields Investments plc on the Alternative Investment Market of the London Stock Exchange, with completion expected on or around 1 December 2020. The new funding will help BrandShield capitalise on the increasing number of new business opportunities it sees, in part caused by the acceleration of online criminal activity caused by the pandemic.

The contract with PSI also adds to BrandShield's growing presence in the US. Around two-thirds of BrandShield's sales are in the US, where, along with Europe and Asia, its products and services are increasingly in demand. BrandShield already works with many global brands and customers that operate in a variety of sectors including financial services, pharmaceuticals, fashion, technology, sports and entertainment. Earlier this year, BrandShield announced it had neutralised over 150 phishing websites targeting the Levi Strauss & Co's brand.

Yoav Keren, BrandShield CEO, said: "One of the biggest sectors being targeted by online scammers and con artists is pharmaceuticals. Cybercriminals across the world are trying to capitalise on peoples' fears about COVID-19 to push counterfeit medicines or launch phishing campaigns by impersonating well-known pharma companies. Fake medicines are a real threat to the health and safety of patients around the world. With, hopefully, vaccines becoming available in the coming months, it is vital the industry gets to grip with online threats. We are excited to be working with the Pharmaceutical Security Institute in helping some of their members fight this danger.

"We see this contract as another example of how large companies are addressing brand protection and online threats by using our services. With our imminent reverse onto AIM and the associated fundraising, we look forward to moving from an under the radar solution during our development phase to becoming the premier provider on the market. I believe that within the next few years all companies will need a solution to counter these developing online threats and we are very well positioned to help them.""

Contacts:

Andrew Lawley

 

Two Shields Investments plc

T: +44 (0)20 3143 8300 

Neil Baldwin / Andrew Emmott

Spark Advisory Partners Limited

(Nominated Adviser)

T: +44 (0) 20 3368 3554

 

 

Robert Emmet

Optiva Securities Limited

(Joint Broker)

 

 

T: +44 (0) 20 3137 1902

Bob Huxford / Robin Tozer

Newgate Communications

T: +44 (0) 7540 106366

E: brandshield@newgatecomms.com

 

About BrandShield

Headquartered in Israel, BrandShield provides digital brand protection and online threat hunting services to protect brands and companies from the financial cost and reputational damage caused by criminal activities, such as phishing and fraud, executive impersonation or the sale of counterfeit goods online. BrandShield's suite of proprietary AI-powered technology works by detecting potential threats, analysing them, prioritising them and then taking them down. The technology uses big data and algorithms to find networks of fraudulent online activity and clusters of counterfeiters. BrandShield has established its own in-house online hunting and enforcement team consisting mostly of qualified lawyers, with experience in IP law.

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
CNTQDLBFBFLZFBV
Date   Source Headline
23rd Oct 20175:04 pmRNSChange of Broking Arrangements
20th Oct 20171:42 pmRNSBoard change
16th Oct 20177:00 amRNS15 Lithium Target Areas identified in Mali
26th Sep 20177:00 amRNSBoard Appointment
25th Sep 20177:00 amRNSPlacing to Raise £900,000
22nd Sep 20177:00 amRNSChange of Nominated Adviser
15th Sep 201712:51 pmRNSIGS Update
15th Sep 201712:46 pmRNSResult of AGM
14th Sep 20177:00 amRNSInvestment in Kalahari Key Mineral Exploration
8th Sep 20177:00 amRNSHolding(s) in Company
4th Sep 20177:00 amRNSInvestor engagement via Vox Markets
1st Sep 20174:58 pmRNSSeminar for shareholders and investors
23rd Aug 20174:20 pmRNSNotice of AGM
22nd Aug 201711:51 amRNSHolding(s) in Company
17th Aug 20175:45 pmRNSHolding(s) in Company
15th Aug 201711:58 amRNSHolding(s) in Company
11th Aug 201712:10 pmRNSNashwan Investment Update
8th Aug 20177:00 amRNSLapse of TAM Mining Limited option
3rd Aug 20177:00 amRNSHolding(s) in Company
27th Jul 20178:20 amRNSVOX Markets Podcast Interview
27th Jul 20177:00 amRNSHolding(s) in Company
26th Jul 20177:00 amRNSCompletion of Mansa Lithium Inc Investment
12th Jul 20174:55 pmRNSHolding(s) in Company
3rd Jul 20177:00 amRNSAgreement
30th Jun 20171:21 pmRNSHolding(s) in Company
30th Jun 20171:18 pmRNSHolding(s) in Company
19th Jun 20171:58 pmRNSProgress Report
16th Jun 20174:25 pmRNSHolding(s) in Company
15th Jun 20174:00 pmRNSHolding(s) in Company
15th Jun 20173:52 pmRNSReplacement: Holding(s) in Company
15th Jun 20173:47 pmRNSReplacement: Holding(s) in Company
13th Jun 20172:40 pmRNSExercise of Warrants
8th Jun 201710:28 amRNSHolding(s) in Company
6th Jun 20177:00 amRNSHolding(s) in Company
31st May 201712:15 pmRNSExercise of Warrants
16th May 20177:00 amRNSFinal Results
3rd May 20175:49 pmRNSHolding(s) in Company
28th Apr 20171:38 pmRNSResult of General Meeting
27th Apr 20177:00 amRNSConditional placing to raise £1 million
18th Apr 20171:54 pmRNSRedemption of Convertible Loan Notes
13th Apr 20177:00 amRNSNon-Executive Director Appointment
12th Apr 20174:20 pmRNSNotice of General Meeting
7th Apr 201711:13 amRNSChange of accounting reference date
31st Mar 20174:17 pmRNSHolding(s) in Company
30th Mar 20177:00 amRNSInvestment in West African Exploration Company
27th Feb 20174:22 pmRNSExtension of Option to Invest in Lithium Project
10th Feb 20172:50 pmRNSGrant of Options and PDMR Dealing
9th Feb 20173:05 pmRNSHolding(s) in Company
7th Feb 20171:45 pmRNSResult of General Meeting
30th Jan 20177:00 amRNSHalf-year Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.